Leucadia National - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
Leucadia National ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,049,542
-44.1%
362,609
-16.5%
0.03%
-44.9%
Q2 2023$5,453,665
+88.5%
434,209
+147.1%
0.05%
+104.2%
Q1 2023$2,893,779175,7000.02%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Casdin Capital, LLC 6,923,574$58,227,2576.44%
Finepoint Capital LP 870,870$7,324,0173.65%
Nextech Invest Ltd. 1,196,409$10,061,8003.05%
MPM BioImpact LLC 1,352,133$11,371,4393.04%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$234,680,7391.93%
EcoR1 Capital, LLC 4,163,824$35,017,7601.18%
Integral Health Asset Management, LLC 800,000$6,728,0000.93%
Alphabet Inc. 1,568,753$13,193,2120.85%
HARBOURVEST PARTNERS LLC 296,402$2,492,7410.85%
Boxer Capital, LLC 1,819,132$15,298,9000.81%
View complete list of RELAY THERAPEUTICS INC shareholders